Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

BUY
$2.92 - $5.83 $7,448 - $14,872
2,551 Added 269.38%
3,498 $11,000
Q1 2024

Apr 25, 2024

SELL
$4.29 - $7.4 $20,840 - $35,949
-4,858 Reduced 83.69%
947 $5,000
Q4 2023

Feb 02, 2024

BUY
$2.23 - $4.49 $11,257 - $22,665
5,048 Added 666.84%
5,805 $25,000
Q3 2023

Nov 01, 2023

SELL
$2.63 - $4.09 $12,079 - $18,785
-4,593 Reduced 85.85%
757 $1,000
Q2 2023

Aug 04, 2023

SELL
$2.6 - $3.58 $13,044 - $17,960
-5,017 Reduced 48.39%
5,350 $18,000
Q1 2023

Apr 27, 2023

BUY
$2.21 - $4.82 $22,911 - $49,968
10,367 New
10,367 $32,000
Q3 2022

Nov 04, 2022

BUY
$2.27 - $3.84 $28,336 - $47,934
12,483 Added 360.47%
15,946 $37,000
Q2 2022

Aug 03, 2022

BUY
$1.64 - $3.3 $5,679 - $11,427
3,463 New
3,463 $9,000
Q1 2022

May 02, 2022

SELL
$2.13 - $3.24 $167,230 - $254,378
-78,512 Closed
0 $0
Q4 2021

Feb 23, 2022

BUY
$2.85 - $6.58 $216,229 - $499,224
75,870 Added 2871.69%
78,512 $238,000
Q2 2021

Aug 12, 2021

BUY
$8.98 - $11.6 $23,725 - $30,647
2,642 New
2,642 $24,000
Q2 2020

Jul 13, 2020

SELL
$7.01 - $13.24 $98,413 - $185,876
-14,039 Closed
0 $0
Q1 2020

Apr 29, 2020

SELL
$6.28 - $14.57 $361,797 - $839,392
-57,611 Reduced 80.41%
14,039 $118,000
Q4 2019

Feb 05, 2020

BUY
$6.5 - $10.73 $443,579 - $732,247
68,243 Added 2003.02%
71,650 $626,000
Q3 2019

Oct 15, 2019

SELL
$8.75 - $12.85 $85,015 - $124,850
-9,716 Reduced 74.04%
3,407 $36,000
Q2 2019

Jul 26, 2019

BUY
$12.3 - $35.76 $62,631 - $182,089
5,092 Added 63.4%
13,123 $166,000
Q1 2019

Apr 18, 2019

SELL
$20.77 - $42.37 $554,247 - $1.13 Million
-26,685 Reduced 76.87%
8,031 $0
Q4 2018

Jan 16, 2019

BUY
$20.07 - $46.7 $563,645 - $1.31 Million
28,084 Added 423.46%
34,716 $706,000
Q3 2018

Oct 23, 2018

SELL
$41.2 - $59.85 $494,276 - $718,020
-11,997 Reduced 64.4%
6,632 $304,000
Q2 2018

Jul 30, 2018

BUY
$48.3 - $68.25 $899,780 - $1.27 Million
18,629 New
18,629 $1.1 Million
Q1 2018

Apr 26, 2018

SELL
$59.7 - $99.25 $202,681 - $336,953
-3,395 Closed
0 $0
Q4 2017

Jan 10, 2018

BUY
$93.85 - $132.45 $318,620 - $449,667
3,395
3,395 $335,000

Others Institutions Holding PBYI

About PUMA BIOTECHNOLOGY, INC.


  • Ticker PBYI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,556,000
  • Market Cap $128M
  • Description
  • Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...
More about PBYI
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.